The transition to the new so-called Medical Device Regulation ("MDR") and In Vitro Diagnostic Regulation ("IVDR"), which establish new rules for the placing on the market of medical devices in the European Union ("EU"), and which were adopted in 2017, has been plagued with uncertainty and delays.